Latest News

Date Title Topic
23 Jan 2014 Risk/Benefit Ratio of New Immunotherapy Strategies Immuno-oncology
Non-Small-Cell Lung Cancer
22 Jan 2014 Ramucirumab in Combination With Paclitaxel Improves Overall Survival in Second Line Treatment for Metastatic Gastric Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
22 Jan 2014 KRAS Profiling in Non-Squamous NSCLC Translational research - Lung and other thoracic tumours
21 Jan 2014 Phase II Trial Results of Bevacizumab in Combination With Radiotherapy and Cisplatin in Locally-Advanced Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
20 Jan 2014 Vemurafenib in Hairy-Cell Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
17 Jan 2014 ESMO Press Commentary: Is Europe Equipped with Enough Medical Oncologists to Face the Increasing Cancer Burden? The Horizon is Still Unknown
16 Jan 2014 Current Therapeutic Options and Development strategies in Cancer Immunotherapy Immuno-oncology
13 Jan 2014 FDA Approves Trametinib in Combination with Dabrafenib for Advanced Melanoma Melanoma - Anticancer agents & Biologic therapy
13 Jan 2014 The Impact of Personalised Medicine in Elderly Patients with Cancer Personalised medicine - Cancer in Special Situations
08 Jan 2014 ESMO E-Learning: What is the Benefit of Drug Therapy in Advanced Gastric Cancer - and Which Drugs Shall we Use?
08 Jan 2014 Personalised Medicine in Melanoma Personalised medicine - Melanoma
06 Jan 2014 Biologicals in the Treatment of Haematological Malignancies Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
03 Jan 2014 Personalised Medicine in Carcinoma of Unknown Primary Personalised medicine - Carcinoma of unknown primary site